Brind.

Biofrontera's acquisition of George Jones includes rights to FDA approval and strengthens commercial efforts.

1 report, 1 independent Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Biofrontera's acquisition of George Jones includes rights to FDA approval and strengthens commercial efforts.

Who's involved

What this event is mainly about
BiofronteraGeorge Jones

How it developed

Newest first. Tap a step to see who reported it.
  1. Biofrontera commercializes its products in the US market.Sub-event
  2. Biofrontera acquires George Jones, securing FDA approval rights.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireBiofrontera Inc. Appoints George Jones as Chief Commercial Officer Woburn, MA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company focused o